Promoting Healthy Lifestyles and a Clean and Safe Environment 732-341-9700 www.ochd.org Maximizing health department resources to identify and prevent.

Slides:



Advertisements
Similar presentations
Emerging and Acute Infectious Disease Branch
Advertisements

HIV Counselling and Testing
1. Interpret a positive HBeAg, Anti- HBcAg, and/or anti-HCV test.
Treatment appropriate Normal or minimal hepatitis Chronic hepatitis Normal or inactive hepatitis Progressive fibrosis Cirrhosis HCC HBeAg Anti-HBe HBV.
Case Identification for the Missouri Perinatal Hepatitis B Prevention Program Libby Landrum, RN, MSN Viral Hepatitis Prevention Manager Bureau HIV, STD,
An Introduction to HIV Incidence Surveillance (HIS) in California California Department of Public Health Office of AIDS.
The Global Burden of Hepatitis C Dr Daniel Lavanchy World Health Organization (WHO) Geneva, Switzerland 3 rd Paris Hepatitis Conference.
The Essentials of Perinatal Hepatitis B Prevention A Training Series for Coordinators and Case Managers.
Texas Perinatal Hepatitis B Prevention Program 2 nd Bi-Annual State Conference Designing an Effective Case Management Program Lisa Jacques-Carroll, MSW.
Perinatal Hepatitis B Prevention
Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Chronic Hepatitis B Surveillance in Santa Clara County Sara H. Cody, MD Deputy Health Officer An evaluation to understand meaning and usefulness of surveillance.
Hepatitis C Best Practice Guidelines Susan Thompson, RN, MPH September 2009.
Hepatitis B: Epidemiology
Hallauer 06/20011 Outcome evaluation of an universal hepatitis B immunisation programme Johannes F. Hallauer M.D. Health Systems Research Charité, Humboldt.
BLOOD BORNE PATHOGEN EXPOSURE Management – What you need to know about Needlesticks and Splashes Amy J. Behrman, MD Occupational Medicine Dept of Emergency.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
Enhancing HIV/AIDS Surveillance in California California Department of Public Health Office of AIDS Guide for Health Care Providers.
HEPATITIS B MARKERS AND VACCINE
Hepatitis web study H EPATITIS W EB S TUDY H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School.
Session 4: Delivery Hospital as Safety Net Lisa Jacques-Carroll, MSW NCIRD, CDC.
HEPATITIS A VIRUS Week Response Clinical illness ALT IgM IgG HAV in stool Infection Viremia EVENTS IN HEPATITIS A VIRUS INFECTION.
Kerriann Parchment GI CBL 2 Part 3 December 2012 Viral hepatitis serology.
Bloodborne Pathogens Occupational Safety and Health Course for Healthcare Professionals.
Epidemiology and Prevention of Viral Hepatitis A to E: Hepatitis A Virus Division of Viral Hepatitis.
PHS GUIDELINE FOR REDUCING TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS, HEPATITIS B VIRUS AND HEPATITIS C VIRUS THROUGH SOLID ORGAN TRANSPLANTATION ACOT.
Unmet Need for Hepatitis C PCR Testing, New York City, Emily McGibbon, MPH June 2011 CSTE Annual Conference.
Hepatitis B Virus 28.
Overview National Hepatitis B Data
Perinatal Hepatitis B Prevention Program (PHBPP) Pat Fineis /02/03.
Why we are here? However, a general lack of understanding exists among health-care professionals regarding the interpretation of screening test results,
Connecticut Immunization Hot Topics Teleconference Series September 2011 NANCY FENLON, RN, MS CDC National Center for Immunization and Respiratory Diseases.
A Cluster of Hepatitis C among Rural, Young Adults – Illinois, 2012 Julia Howland, MPH CPH CDC/CSTE Applied Epidemiology Fellow Illinois Department of.
Research on HBV in SCDC Xi Zhang, Ye Lu Shanghai Municipal Center for Disease Control and Prevention May, 2008.
Assessing the Response to Hepatitis B Immunizations in HIV-Positive Adults: Results from the 550 Clinic cohort study Camila Calderon 1, Anupama Raghuram.
Viral Hepatitis Australian Family Physician Vol. 30 No.5, May 2001 Presented by 郭詠怡 Date presented:25/8/2003.
Viral Hepatitis Program Perinatal Case Management Amy E. Warner, M.P.H. Colorado Department of Public Health.
INTRODUCTION High incidence rate High incidence rate Do not grow in the laboratory Do not grow in the laboratory Discovered in 1964 Discovered in 1964.
Hepatitis B Virus Dr R V S N Sarma., M.D., [SLIDE 1] Title Slide
USE OF ACUTE HEPATITIS SURVEILLANCE TO EVALUATE PROGRAM FOR VIRAL HEPATITIS PREVENTION AND CONTROL Central Asian Program, DIH, EPO, CDC.
Overview of Hepatitis B, C, and D Epidemiology in Eastern Europe and the Newly Independent States Michael O. Favorov MD, Ph.D., D.Sc. CDC Central Asia.
CHRONIC HEPATITIS B SEROLOGY. Antigens HBsAg -Found on the surface of the intact virus and in serum as unattached particles -Earliest detectable marker.
Survey of hepatites VirusRelationshipTransmission HAVPicornavirusfaecal-oral HBVSpecial group of DNA viruses sexual, blood HCV (+ HGV)Flavivirusblood HDVDelta.
Hepatitis B The Basics David Wong University of Toronto March 2005.
Injection Safety: Updates from Michigan and the U.S. October 9, 2015 Emily Goerge, MPH, MSN, RN, CIC.
Need for vaccination for vaccine preventable hepatitis in methadone maintenance treatment Randy Seewald, MD 1,2,3, Eli Kamara, BS 2, Ruy Tio, DO 1,2, Rashiah.
Hepatitis Virus. Primary members HAV HBV HCV HDV HEV.
A Universal Testing Programme for Blood Borne Viruses in an Urban Emergency Department – a call for widespread ED testing in Ireland S O’Connell 1, D Lillis.
Viral Hepatitis Program Management of Babies Born to HBsAg- Positive Mothers Vickie Weeast Perinatal Hepatitis B Case.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Evaluation of Hepatitis B surveillance system in Armenia, 2014 AUTHORS Karine Gevorgyan Lusine Paronyan Shushan Sargsyan Artavazd Vanyan NCDC, Armenia.
Isolated Hepatitis B Core Antibody
Lessons Learned and Novel Investigation Techniques in Response to a Large Community Outbreak of HIV-1 infection Philip J. Peters MD HIV Testing and Biomedical.
Serologic markers and molecular epidemiology of HBV from an HIV infected cohort from Cameroon Tshifhiwa Magoro 1, Emmaculate Nongpang 2, Lufuno Mavhandu.
CHRONIC HEPATITIS B SEROLOGY
Prevention of Perinatal and Childhood Hepatitis B Virus Infections Background on Where We’ve Been Lisa Jacques-Carroll, MSW Immunization Services Division,
MICROBIOLOGY IRS. Gastroenteritis 1) Major cause of infantile death 2) Feacal-oral transmission 3) Gastroenteritis cause dehydration 4) 50 % of all causes.
BARBARA DOMMERT-BRECKLER RN BSN QUALITY IMPROVEMENT DIRECTOR NORTHWEST RENAL NETWORK Hepatitis B: Anti-bodies, Antigens and Immunity 7/9/2016.
Managing Occupational Risks for Hepatitis B & C Transmission in the Health Care Settings BY DR:
VIRAL DISEASES OF LIVER DR.JEYAKUMAR NELSON UNIT OF MICROBIOLOGY MBBS -BATCH 17.
Hepatitis C Virus Program in Chicago
In The Name of God.
Laboratory Diagnosis of Infectious Diseases
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
RISK R isk of Perinatal and Early Childhood Infection
Hepatitis Primary Care: Clinics in Office Practice
Division of Viral Hepatitis
Using Whole Genome Sequencing Analysis in California
Ebola Facts October 15, 2014.
Hepatitis Training in a STD Clinical Program
Presentation transcript:

Promoting Healthy Lifestyles and a Clean and Safe Environment Maximizing health department resources to identify and prevent outbreaks of healthcare associated transmission of viral hepatitis

Promoting Healthy Lifestyles and a Clean and Safe Environment Presenter Disclosures Patricia High, MHS, MCHES “No relationships to disclose” The following personal financial relationships with commercial interests relevant to this presentation existed during the past 12 months:

Promoting Healthy Lifestyles and a Clean and Safe Environment Learning Objectives Describe an investigation protocol for viral hepatitis that maximizes both local health department resources and public health impact. Name investigation triggers for viral hepatitis that prioritize acute cases and those with healthcare associated exposures.

Promoting Healthy Lifestyles and a Clean and Safe Environment Background Transmission of viral hepatitis from healthcare associated exposures is concerning in light of recently recognized outbreaks of hepatitis B and C. Prompt identification and investigation of suspected healthcare associated cases is needed to ascertain the source of illness and to implement appropriate control measures. Local health department resources are limited and the burden of hepatitis makes prioritization and investigation of cases difficult.

Promoting Healthy Lifestyles and a Clean and Safe Environment Background Since 1999, 620 patients were infected in 51 outbreaks Majority of outbreaks (42 out of 51) occurred in non- hospital settings 20% of outbreaks occurred between 7/ /2009 In 2009 alone, more than 31,000 people notified of healthcare associated exposure to bloodborne pathogens – Of those tested, 146 people were infected with HBV or HCV and 5 were infected with HIV Thompson NT et al. Abstract #396. A review of hepatitis B and C virus infection outbreaks in healthcare settings, Fifth Decennial Conference on Healthcare-Associated Infections 2010.

Promoting Healthy Lifestyles and a Clean and Safe Environment New Jersey Outbreak Two women diagnosed with acute HBV infection; both received chemotherapy at the same physician’s office. Onsite inspection revealed multiple breaches in infection control and warranted notification of patients to be tested for bloodborne pathogens. Of 2,700 patients notified, test results were available for 1,394 (51.6%). Twenty-nine outbreak-associated HBV cases were identified.

Promoting Healthy Lifestyles and a Clean and Safe Environment New Jersey Outbreak Specimens from 11 case-patients demonstrated 99.9%-100% nucleotide identity on phylogenetic analysis at the CDC. Investigation underscores the need for prompt identification and investigation of healthcare associated transmission of HBV and HCV. Served as an impetus behind an in-depth look at local investigation practices in New Jersey.

Promoting Healthy Lifestyles and a Clean and Safe Environment Needs Assessment Cross-sectional survey conducted to assess hepatitis investigation practices in New Jersey. Total of 114 local health jurisdictions in NJ, but only 58 respondents who completed the survey (50.8%). – 7 respondents (12%) from LINCS agencies – 51 respondents (88%) from local health departments Respondents were asked about the investigation of routine HBV and HCV reports as well as cases with healthcare associated exposures.

Promoting Healthy Lifestyles and a Clean and Safe Environment Needs Assessment Fifty-two respondents reported having a total of 28,772 Hepatitis B and 49,720 Hepatitis C reports between TOTAL REPORTSAverage by Respondent # Hepatitis B Reports28, # Confirmed Acute Cases63912 # Acute Cases ≥65 Years1553 # Hepatitis C Reports49, # Confirmed Acute Cases2705 # Acute Cases ≥65 Years361

Promoting Healthy Lifestyles and a Clean and Safe Environment HBV Investigation Protocol For the purposes of HBV surveillance in New Jersey, LHDs must investigate cases of acute HBV, newly diagnosed chronic HBV and perinatal HBV infection to identify clusters or outbreaks, provide counseling and ensure appropriate prophylaxis of contacts. In order to better focus efforts, individuals with isolated HBcAb-total, HBeAb or HBsAb do not need to be entered into CDRSS and do not require investigation. Individuals with HBsAg, HBeAg, HBcIgM and all HBV DNA testing results must be investigated.

Promoting Healthy Lifestyles and a Clean and Safe Environment Needs Assessment With lab test results suggestive of acute HBV infection, 33% of respondents, at least rarely, close out the case without investigation 17% will rarely or never contact the patient if the physician does not respond to an inquiry

Promoting Healthy Lifestyles and a Clean and Safe Environment HCV Investigation Protocol For the purposes of HCV surveillance in New Jersey, all cases of laboratory-confirmed HCV which have NOT been reported as ACUTE can be designated as CHRONIC-confirmed and closed without further investigation.

Promoting Healthy Lifestyles and a Clean and Safe Environment Needs Assessment Anti-HCV tests are often ordered as part of initial screening, are not confirmatory, and do not need to be reported to public health.

Promoting Healthy Lifestyles and a Clean and Safe Environment Needs Assessment If MD reports an acute HCV infection, 20% will rarely or never contact the patient Reasons for not contacting the patient: – Concerned about patients’ reaction – MDs don’t want LHDs to contact their patients

Promoting Healthy Lifestyles and a Clean and Safe Environment Needs Assessment If more than one acute case of HBV or HCV was identified with the same healthcare exposures, 29.5% of respondents would document it in CDRSS and close the case without additional action.

Promoting Healthy Lifestyles and a Clean and Safe Environment Results Reports of hepatitis, particularly HCV, are among the most voluminous notifiable disease reports received by public health. The burden of investigating every hepatitis report can overwhelm local resources. By targeting investigations towards HBV and HCV cases that have the potential for an effective public health response, those with acute illness and those with possible healthcare exposures, local resources can be maximized and disease burden reduced.

Promoting Healthy Lifestyles and a Clean and Safe Environment Results Triggers for investigation of suspect acute or healthcare associated cases delineated Training needs identified – Laboratory test interpretation and case classification – Standardized hepatitis investigation guidelines and forms – Infection control for ambulatory care and other healthcare settings -- PENDING

Promoting Healthy Lifestyles and a Clean and Safe Environment Triggers for Investigation Laboratory report of HBcIgM Laboratory report of HBsAg in female aged yrs Positive hepatitis B or C markers in person ≥ 65 yrs Positive hepatitis B or hepatitis C markers in person who resides in a long-term care facility Clinician-reported acute viral hepatitis Clinician-reported viral hepatitis seroconversion

Promoting Healthy Lifestyles and a Clean and Safe Environment IgM anti-HBc HBsAg Weeks after Exposure Titer HBeAganti-HBe Symptoms anti-HBs Total anti-HBc HBV DNA Window Period HBV Serology and Immunology

Promoting Healthy Lifestyles and a Clean and Safe Environment Laboratory Test Interpretation Hepatitis Serology Serology as Recorded in CDRSS HBsAg HBV SURFACE ANTIGEN - A protein on the surface of HBV; it can be detected in high levels in serum during acute or chronic HBV infection. The presence of HBsAg indicates that the person is infectious. The body normally produces antibodies to HBsAg as part of the normal immune response to infection. HBsAg is the antigen used to make hepatitis B vaccine. HBcIgM HBV CORE IGM ANTIBODY - Positivity indicates recent infection with HBV (<6 mos) indicating acute infection. HBsAb HBV SURFACE AB - The presence of anti-HBs is generally interpreted as indicating recovery and immunity from HBV infection. Anti-HBs also develops in a person who has been successfully vaccinated against hepatitis B. HBeAg HBV SURFACE LITTLE E ANTIGEN - HBeAg screening typically is used for the management of patients with chronic infection. The presence of HBeAg correlates with high levels of viral replication. Hepatitis Serology ResultInterpretation HBsAgNegative Susceptible HBcIgMNegative HBsAbNegative HBsAgNegative Immune due to natural infection HBcAbPositive HBsAbPositive HBsAgNegative Immune due to hepatitis B vaccination HBcAbNegative HBsAbPositive HBsAgPositive Acutely infected HBcAbPositive HBcIgMPositive HBsAbNegative HBsAgPositive Chronically infected HBcAbPositive HBcIgMNegative HBsAbNegative

Promoting Healthy Lifestyles and a Clean and Safe Environment Laboratory Test Interpretation Hepatitis SerologyResultInterpretation HBsAgPositive 1.Chronically infected (HBcAb+) 2.Recent receipt of HBV vaccination possible (HBcAb-) HBcIgMPositive 1.Acute infection (HBsAg+) 2.Resolving acute infection (HBsAg- <6 months) 3.Resolved infection with a failure of HBcIgM to seroconvert to HBcAb+ alone (HBsAg- >6 months) HBsAgPositive 1.Acute infection HBcIgMPositive HBeAgPositive1.Chronically infected, highly infectious (HBsAg+, HBcIgM-) 2.Acute infection, highly infectious (HBsAg+, HBcIgM+)

Promoting Healthy Lifestyles and a Clean and Safe Environment Healthcare Associated Hepatitis Several instances where the transmission of viral hepatitis has occurred in healthcare settings owing to poor injection practices and other breaches in infection control. Preventable exposures are likely not being identified following the current investigation procedures. Acknowledging that resources for investigating HBV and HCV are limited, guidelines provide triggers for investigation that prioritize acute cases and cases requiring public health intervention.

Promoting Healthy Lifestyles and a Clean and Safe Environment Standardized Guidelines for Investigating cases of HBV and HCV

Promoting Healthy Lifestyles and a Clean and Safe Environment Conclusion Training needs were incorporated into the local investigation guidelines as locally-sponsored best practices. NJDHSS-sponsored training on investigating viral hepatitis was provided statewide to local public health investigators. – Still need training/skills in ambulatory care infection control assessment New Jersey became one of only 3 states receiving a CDC grant to improve awareness of appropriate injection safety and control.

Promoting Healthy Lifestyles and a Clean and Safe Environment

Promoting Healthy Lifestyles and a Clean and Safe Environment Conclusion By prioritizing viral hepatitis investigation, local investigation resources are optimized to provide maximum public health impact.

Promoting Healthy Lifestyles and a Clean and Safe Environment Thank you! Patricia High, MHS, MCHES Ocean County Health Department Toms River, NJ Special thanks and acknowledgement to Kimberley Cervantes of the Cape May County Health Department for her partnership in this assessment and the review of this presentation.